Single-dose study of M707102 in healthy subjects

Phase 1

• Conditions: Actinic keratosis

• Registration Number: JPRN-jRCT2071230090
• Lead Sponsor: ishiura Tomoyuki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-11-19
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 16

Inclusion Criteria

Male subjects from 18 to 49 years of age (at the time of informed consent)

Exclusion Criteria

(1) Individuals with a history or complications of any of the following diseases
1)Actinic keratosis, porphyria
2)Photosensitivity, metabolic diseases such as aminoaciduria, idiopathic or immune diseases such as polymorphic light eruption, genetic diseases such as xeroderma pigmentosum, and diseases for which onset or exacerbation occur due to exposure to sunlight such as systemic lupus erythematosus and pemphigus
(2) Individuals with a history of allergy or hypersensitivity (including skin hypersensitivity) to any ingredient or metabolite of the investigational medicinal product
(3) Individuals who are judged to be unsuitable as subject by the principal (sub) investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety, Pharmacokinetics